Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B

The immunogenicity and safety of a new recombinant hepatitis B vaccine from the Instituto Butantan (Butang®) were evaluated in a multicenter, double-blind, prospective equivalence study in three centers in Brazil. Engerix B® was the standard vaccine. A total of 3937 subjects were recruited and 2754...

Full description

Bibliographic Details

Published in:	Memorias do Instituto Oswaldo Cruz
Main Authors:	Reinaldo Menezes Martins, Gilberta Bensabath, Luiz Claudio Arraes, Maria de Lourdes Aguiar Oliveira, Juliana Custódio Miguel, Glayse Glayde Barbosa, Luiz Antonio Bastos Camacho
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 2004-12-01
Subjects:	hepatitis B vaccine recombinant vaccines immunization
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000800014